Glucocorticoid (GC) treatment of human trabecular meshwork (HTM) cells produces delayed, progressive cellular and extracellular protein/glycoprotein inductions with characteristics matching those ...

In a healthy eye, excess aqueous humor exits through the trabecular meshwork, which are canals located between your iris (the colored part of the eye) and cornea (the clear outer portion).

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases ...